3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
88
Phase 2
6
Phase EARLY_PHASE1
1
Phase 2/3
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Breast Neoplasms
13
Neoplasms
12
Glioma
12
Prostatic Neoplasms
11
Glioblastoma
11
Colorectal Neoplasms
10
Brain Neoplasms
10
Pancreatic Neoplasms
9
Neoplasm Metastasis
9
Melanoma
8
Lymphoma, B-Cell
8
Lymphoma
8
Recurrence
7
Multiple Myeloma
7
Carcinoma, Renal Cell
6
Triple Negative Breast Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Sarcoma
5
Carcinoma, Non-Small-Cell Lung
5
Skin Neoplasms
4
Head and Neck Neoplasms
4
Carcinoma, Hepatocellular
4
Advanced Solid Tumors
4
Solid Tumor
3
Pituitary Neoplasms
3
Neoplasms, Plasma Cell
3
Myelodysplastic Syndromes
3
Lymphoma, Follicular
3
Lung Neoplasms
3
Carcinoma, Transitional Cell
3
Interventions
Tablets
1
Roflumilast
1
Nadolol
1
Isoproterenol
1
Exercise
1
Carvedilol
1
Bisoprolol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Motor Activity
×
90 days
×
Clear all
NCT06643221
2026-06-05
Allo-X
University of Arizona
Phase EARLY_PHASE1
Recruiting
200 enrolled